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Upregulation of GADD153 by Butyrate:
Involvement of MAPK
David W. Scott, Jennifer M. Longpre, and George Loo
Butyrate inhibits the proliferation of cancer cells, but the early molecular events initiated by butyrate have not
been fully identified. Herein, butyrate is shown to affect the growth arrest and DNA damage–inducible gene 153
(GADD153) in HCT-116 human colon adenocarcinoma cells. Despite absence of any detectable cellular DNA
damage, the expression of GADD153 was upregulated before several features characteristic of apoptosis ap-
peared. Butyrate-induced upregulation of GADD153 mRNA was attenuated by actinomycin D, but apparently
not by cycloheximide. In investigating possible involvement of MAPK in mediating the effect of butyrate on
GADD153 mRNA expression, the extracellular regulated kinase (ERK) inhibitor PD98059, but neither the JNK
inhibitor SP600125 nor the p38 MAPK inhibitor SB203580, blunted the ability of butyrate to upregulate
GADD153 mRNA expression. U0126, a selective inhibitor of upstream MEK, had a similar effect as PD98059 on
butyrate-induced GADD153 mRNA upregulation. Collectively, these findings suggest that butyrate caused
activation of the GADD153 gene at the level of transcription involving mainly the MEK=ERK branch of the
MAPK signal transduction pathway. Moreover, these molecular events were not the result of any DNA damage
and occurred before several features characteristic of apoptosis became evident.
Introduction
The four-carbon saturated carboxylic acid, butyrate,is often recognized as a compound that can suppress the
growth or proliferation of cancer cells by different means.
Butyrate affects the expression of genes that regulate the cell
cycle. For example, butyrate inhibited the proliferation of
human colon adenocarcinoma cells by inducing p21 (WAF1)
gene expression (Nakano et al., 1997; Archer et al., 1998).
Moreover, this effect of butyrate was similar to trichostatin A,
a specific histone deacetylase inhibitor, suggesting that bu-
tyrate promoted histone hyperacetylation in producing its
molecular effect. Apparently, butyrate creates a cellular en-
vironment where the cis-elements localized in the promoter
region of the p21 gene become more accessible for binding to
the appropriate transcription factors that are involved in p21
gene activation. Whereas p53 is not critical (Nakano et al.,
1997; Archer et al., 1998), at least three other transcrip-
tion factors have been considered as potential mediators of
butyrate-induced p21 gene activation. Sp1 seems to be in-
volved, based on the original finding of at least two Sp1 sites
in the p21 gene promoter (Nakano et al., 1997; Sowa et al., 1997)
that constitute butyrate-responsive cis-elements. On the other
hand, it has been reported that Sp3, rather than Sp1, could be
more pivotal in p21 gene activation by butyrate (Sowa et al.,
1999). A role for ZBP-89 has also been reported (Bai and
Merchant, 2000). Following transcriptional activation and
translation of transcript, p21 protein triggers cell cycle arrest
at the G1 phase by inhibiting cyclin-dependent kinases.
In considering other effects of butyrate in inhibiting cancer
cell proliferation, it is known that butyrate can promote dif-
ferentiation in certain cancer cell lines, such as Caco-2 colo-
nocytes (Litvak et al., 1998). Alternatively, butyrate can
induce apoptosis in Caco-2 colonocytes, which was reported
to occur via the mitochondrial pathway involving release of
cytochrome c and activation of caspases (Ruemmele et al.,
2003). The molecular mechanism of the apoptotic effect of
butyrate is unclear, but it has been reported that butyrate-
induced apoptosis happens in association with downreg-
ulated expression of the antiapoptotic genes, Bcl-2 and
Bcl-XL (Litvak et al., 1998). In analyzing the expression of
gene products, butyrate has been shown to simultaneously
increase expression of the proapoptotic protein, bak, and de-
crease the expression of bcl-xl protein in inducing caspase-
mediated apoptosis (Ruemmele et al., 2003).
It is likely that butyrate stimulates early-response events
that precede the initiation of cell cycle arrest and=or cell
death. To gain a better understanding along this line, the pri-
mary aim of the present study was to determine if butyrate
influences the expression of a specific member of the growth
Cellular and Molecular Nutrition Research Laboratory, Department of Nutrition, University of North Carolina at Greensboro, Greensboro,
North Carolina.
DNA AND CELL BIOLOGY
Volume 27, Number 11, 2008
ª Mary Ann Liebert, Inc.
Pp. 607–614
DOI: 10.1089=dna.2008.0773
607
arrest and DNA damage-inducible genes (GADD). GADD
expression is often upregulated a relatively short time after
cells have been subjected to a stressful or potentially lethal
environment, such as created by a strong oxidant (Oh-Hashi
et al., 2001) or genotoxic compound (Scott et al., 2005). DNA
microarray analysis revealed that butyrate upregulates the
GADD45A gene in HCT-116 human colon adenocarcinoma
cells (Daly and Shirazi-Beechey, 2006). We tested the hy-
pothesis that exposing HCT-116 cells to butyrate would
upregulate the GADD153 gene with an involvement of a
mitogen-activated protein kinase (MAPK). It was found that
butyrate stimulates extracellular regulated kinase (ERK)–
dependent induction of GADD153 mRNA expression, as part
of an apparent molecular cascade initiated not as a result of
any DNA damage and happening before the subsequent
onset of apoptosis.
Materials and Methods
Materials
The HCT-116 human colon adenocarcinoma cell line
was obtained from the American Type Culture Collection
(Manassas, VA). PD98059 and SB203580 were purchased
from Calbiochem (San Diego, CA), and SP600125 from Tocris
(Ellisville, MO). U0126 was purchased from BioMol (Ply-
mouth Meeting, PA). Butyrate and all other reagents were
purchased from Sigma Chemical (St. Louis, MO) unless
otherwise stated.
Cell culture and treatment
HCT-116 colonocytes were propagated in McCoy’s 5A
medium (Sigma) that was supplemented with 100 M fetal
bovine serum (BioWhittaker, Walkersville, MD), 2 mM glu-
tamine, 0.54 M fungizone, 100,000 units=L penicillin, and
100 mg=L streptomycin (last four items from Atlanta Biolo-
gicals, Atlanta, GA). Upon reaching 70–80% confluency, the
cells were exposed to 0–16 mM butyrate for 0–48 h depend-
ing on the experiment. Cells were also exposed to 10mM
trichostatin for comparison with butyrate. In some experi-
ments, the cells were coincubated with either 5 g=mL acti-
nomycin D (Act D) or 8mg=mL cycloheximide, and butyrate.
In other experiments, cells were coincubated with PD98059
(0–50 mM), SB203580 (0–10 mM), SP600125 (0–10 mM), U0126
(0–50 mM), or staurosporine (0–1mM), and butyrate.
Assessment of cellular DNA damage
The structural integrity of DNA in the cells was assessed
by the alkaline comet assay, as described previously (Po-
wolny et al., 2001). Briefly, harvested cells were suspended in
0.5% agarose and aliquots of the suspension pipetted onto
frosted glass slides, which had been precoated with the aga-
rose. After congealing of the agarose, the slides were then
immersed in ice-cold lysis buffer (2.5 M NaCl, 100 mM
NaEDTA, 10 mM Tris, 300 mM NaOH, 10% DMSO, and 1%
Triton X-100) for 1 h, and then placed in electrophoresis
buffer (300 mM NaOH, 1 mM EDTA) for 20 min before ini-
tiating electrophoresis (300 mA for 20 min). After electro-
phoresis, the slides were submerged twice in neutralization
buffer (0.4 M Tris–Cl, pH 7.5) for 5 min, before staining with
ethidium bromide and viewing.
Annexin V-FITC binding assay
HCT-116 colonocytes that had been grown and treated
with butyrate in chamber slides were washed twice with cold
phosphate-buffered saline (PBS). The washed cells were
equilibrated for 10 min in binding buffer (10 mM HEPES,
140 mM NaCl, 2.5 mM CaCl2, and pH 7.4). After equilibra-
tion, the binding buffer was removed from the chamber slide.
Then, fresh binding buffer but containing annexin V-Alexa
Fluor 488 conjugate (Molecular Probes, Eugene, OR) was
pipetted into the chamber slide for 15 min of incubation.
After washing with binding buffer, cells on the slides were
viewed on an Olympus BX-60 fluorescence microscope=SPOT
digital camera.
TUNEL assay
HCT-116 colonocytes were washed three times and resus-
pended in PBS. Aliquots of the cell suspension were pipetted
onto lysine-coated glass slides for centrifugation in a Stat
Spin Cytofuge. To fix the cells, slides were immersed in 4%
formaldehyde solution in PBS for 25 min and placed overnight
in 70% ethanol at 208C. The TUNEL (terminal deoxynuc-
leotidyl transferase–mediated dUTP nick end labeling) assay
was then performed using a kit along with set of instructions
from Promega (Madison, WI). The cell samples were exam-
ined by fluorescence microscopy as above.
Determination of GADD153 mRNA expression
Total RNA was isolated from the cells using an RNeasy
Mini kit (Qiagen, Valencia, CA). The expression levels of
GADD153 mRNA were determined by multiplex relative RT-
PCR analysis of total RNA using a Qiagen OneStep RT-PCR
kit and gene-specific primers, as described previously (Scott
et al., 2005).
Determination of GADD153 protein expression
by immunocytofluorescence microscopy
and Western blotting analysis
Cells in LabTek chamber slides were fixed with 4% form-
aldehyde in PBS at 258C for 30 min and then permeabilized
with 0.2% Triton X-100 in PBS at 48C for 5 min. The slides
were blocked with 1% bovine serum albumin (BSA) in PBS at
258C for 3 h. The cells were then incubated overnight at 48C
with 1:500 dilution of rabbit polyclonal anti-GADD153 anti-
body (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) in the
blocking buffer. Next, the cells were incubated with 1:1000
dilution of goat anti-rabbit IgG conjugated to Alexa Fluor 488
(Molecular Probes) in the blocking buffer. After thorough
washing in PBS, the slides were mounted and cells exam-
ined. Western blotting analysis for GADD153 protein was
performed as previously described (Scott et al., 2005).
Results
Evaluation of DNA structural integrity
As shown in Figure 1A, HCT-116 colonocytes that were
exposed to 8 mM butyrate for a range of times (0–6 h) had
nucleoids that were spherical, reflecting no DNA damage.
This was also the case with cells exposed to butyrate for 16 h
(data not shown). In contrast and for the purpose of com-
parison, cells exposed to the reactive oxygen species, hydro-
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gen peroxide (H2O2), had nucleoids with the typical comet
appearance, reflecting DNA single-strand breaks.
Cellular features characteristic of apoptosis
in HCT-116 colonocytes exposed to butyrate
Some of the HCT-116 colonocytes in the Petri dishes began
rounding up within 24 h of treatment with 4 mM butyrate.
When examined later at 36 h (Fig. 1B), many of the cells
showed more distinctive morphological changes—that is,
cell shrinkage, cell surface blebbing, and cell break-up into
smaller bodies or remnants. It is well known that, during the
early stages of apoptosis, phosphatidylserine translocates
from the inner to outer leaflet of the plasma membrane. To
determine if such a process happens in butyrate-treated
HCT-116 colonocytes, the annexin V-Alexa Fluor 488 binding
assay was performed to detect any translocated phosphati-
dylserine at the cell surface. As shown in Figure 1C, more of
the butyrate-treated cells than the untreated cells bound the
annexin V-Alexa Fluor 488 probe (giving them a bright green
fluorescence at the cell surface).
It is also widely known that DNA becomes fragmented
during the late stages of apoptosis. To determine if DNA
fragmentation occurs in butyrate-treated HCT-116 colono-
cytes, the TUNEL assay was performed. As shown in Figure
1D, more of the butyrate-treated cells than the untreated cells
tested positive, as indicated specifically by those cells emit-
ting bright green fluorescence (against the red background
fluorescence produced by counterstaining all the cells with
propidium iodide).
Effect of butyrate on GADD153 mRNA and protein
expression in HCT-116 colonocytes
Upon performing multiplex relative RT-PCR analysis
using gene-specific primers for GADD153 and the internal
control b-actin, it was found that GADD153 mRNA was
expressed constitutively in HCT-116 colonocytes (Fig. 2A, B).
However, exposing the cells to butyrate increased GADD153
mRNA expression. This effect of butyrate was both concen-
tration dependent (Fig. 2A) and time dependent (Fig. 2B).
To determine if butyrate caused any changes in GADD153
protein expression in HCT-116 colonocytes, immunocytofluo-
rescence microscopy was performed using an anti-GADD153
polyclonal antibody and the counterstain, propidium iodide.
Representative results are shown in Figure 2C. No visual evi-
dence of GADD153 protein expression can be seen in any of
the cells of the untreated or control sample (left image), as
indicated by the absence of green fluorescence. In the butyrate-
treated sample (right image), some of the cells expressed
GADD153 protein to varying extents, as indicated by the pres-
ence of green fluorescence. Expression of GADD153 protein
was also assessed by western blotting analysis (Fig. 2D), which
revealed that induction of GADD153 protein by butyrate was
only slight (in comparison to cells exposed to DOC as a positive
control) and not clearly concentration-dependent. It is possible
that a large portion of the GADD153 transcript is not being
translated. Alternatively, there could be rapid proteosomal
turnover of part of the pool of newly synthesized GADD153
protein.
Effect of actinomycin D and cycloheximide
on GADD153 mRNA upregulation caused
by butyrate in HCT-116 colonocytes
To determine whether butyrate increases GADD153
mRNA at the level of transcription, an experiment using the
RNA synthesis inhibitor, actinomycin D, was performed
(Fig. 3A). As before, butyrate increased GADD153 mRNA
expression in HCT-116 colonocytes (lane 2) when compared
to control cells (lane 1). However, actinomycin D prevented
FIG. 1. Absence of detectable DNA damage and display of features characteristic of apoptosis in butyrate-treated HCT-116
colonocytes. In (A), cells were treated with 8 mM butyrate for 0–6 h, and also with 300mM H2O2 for 0.5 h as a positive control.
Then, the comet assay was performed. In (B), cells were treated with 4 mM butyrate for 36 h and then examined by light
microscopy. In (C), cells were treated with 4 mM butyrate for 24 h, before performing the annexin V binding assay with
subsequent visualization of the cells by fluorescence microscopy using a triple-band filter. In (D), cells were treated with
4 mM butyrate for 48 h, before performing the TUNEL assay with subsequent visualization of the cells by fluorescence
microscopy using a triple-band filter. The results are representative of four different experiments.
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the GADD153 mRNA upregulation caused by butyrate (lane
3). Therefore, these data would imply that butyrate-induced
GADD153 mRNA upregulation is due more likely to in-
creased synthesis, rather than to greater stability, of the
transcript.
To determine if protein synthesis is required for butyrate-
induced GADD153 mRNA upregulation, the standard protein
synthesis inhibitor, cycloheximide, was considered as being
the ideal tool to use. The results of the experiment turned out to
be ambiguous, but nevertheless yielded some additional in-
formation regarding the identity of other substances capable of
modulating GADD153 mRNA expression. In this experiment,
we opted to incubate HCT-116 colonocytes with butyrate at
8 mM, which is the highest concentration tested in the present
study. As shown in Figure 3A, it would initially appear that
cycloheximide (8mg=mL) did not affect the capacity of buty-
rate to increase GADD153 mRNA expression, in comparing
lane 4 with lane 2. As can be seen in Figure 3B, a range of
cycloheximide concentrations (0–10mg=mL) was also tested,
and cycloheximide had no observable effects on butyrate-
induced upregulation of GADD153 mRNA expression, in
comparing lane 2 with lanes 3–6. However, further examina-
tion of Figure 3B reveals that cycloheximide by itself actually
increased GADD153 mRNA expression noticeably, in com-
paring lane 1 with lanes 7–10. Therefore, because of this in-
terfering, independent upregulatory effect of cycloheximide
on GADD153 mRNA expression, no clear conclusion can
be drawn concerning a requirement for protein synthesis in
butyrate-induced GADD153 mRNA upregulation.
FIG. 2. Increased expression of GADD153 mRNA and pro-
tein in butyrate-treated HCT-116 colonocytes. Cells were
treated with 0–8 mM butyrate for 14 h (A) or with 4 mM
butyrate for 0–20 h (B). Then, multiplex relative RT-PCR
analysis was performed to determine expression of the target
gene, GADD153, and internal control gene, b-actin. The bar
graphs above each of the representative gel images denote
the changes (fold differences, average SD) in GADD153 ex-
pression (normalized against b-actin) relative to control. In
(C), cells were treated with 4 mM butyrate for 15 h. Then,
immunocytofluorescence microscopy was performed to ana-
lyze GADD153 protein expression, using anti-GADD153 pri-
mary antibody along with a secondary antibody conjugated
to Alexa Fluor 488 (green fluorescence). Counterstaining was
achieved with propidium iodide (red fluorescence). The cells
were viewed with a triple-band filter. In (D), cells were treated
with 0–16 mM butyrate for 20 h and western blotting analy-
sis performed, incorporating cells exposed for 4 h to 300mM
deoxycholate (DOC) as a positive control. All results are rep-
resentative of four different experiments.
FIG. 3. Impact of actinomycin D and cycloheximide on
butyrate-induced GADD153 mRNA upregulation in HCT-116
colonocytes. The cells were treated with butyrate for 8 h, with
either actinomycin D or cycloheximide being added at the 4-h
mid-time point. Then, multiplex relative RT-PCR analysis
was performed to determine expression of the target gene,
GADD153, and internal control gene, b-actin (A). In (B), a
similar experiment was performed but using only cyclohex-
imide at varying concentrations. The bar graphs above each
of the representative gel images denote the changes (fold
differences, average SD) in GADD153 expression (normal-
ized against b-actin) relative to control. The results are rep-
resentative of three different experiments.
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Effect of protein kinase inhibitors on butyrate-induced
upregulation of GADD153 mRNA and protein
expression in HCT-116 colonocytes
MAPKs have been reported to be involved in upregulat-
ing GADD gene expression (Rolli-Derkinderen and Gaestel,
2000; Oh-Hashi et al., 2001; Sarkar et al., 2002). Hence, we first
asked the question if a selective chemical inhibitor of ERK,
specifically PD98059, might have an inhibitory effect on
butyrate-induced GADD153 mRNA upregulation. At a con-
centration of 25 mM, PD98059 noticeably blunted GADD153
mRNA upregulation caused by 1, 2, 4, or 8 mM butyrate
(Fig. 4A). Further, testing PD98059 at double the concentra-
tion (50mM) did not produce an additional blunting effect
of significant proportion on butyrate-induced GADD153
mRNA upregulation (Fig. 4B). Because butyrate is often used
as an inhibitor of histone deacetylase (Nakano et al., 1997;
Archer et al., 1998), this prompted accompanying experiments
(Fig. 4A, B) to show that trichostatin, also a known histone
deacetylase inhibitor, increases GADD153 mRNA expression
as well, although further investigation of trichostatin’s effect
was not pursued.
In performing an experiment to determine the impact of
PD98059 on butyrate-induced upregulation of GADD153
protein expression (Fig. 5A), immunocytofluorescence mi-
croscopy again revealed that cells in the control sample ex-
pressed very little, if any, GADD153 protein, as indicated by
the presence of only dim green background fluorescence,
when viewed with the fluoroscein filter (left upper image).
In the butyrate-treated sample, some of the cells exhibited
bright green fluorescence and hence expressed GADD153
protein (middle upper image). Most importantly, it can be
seen that PD98059 was effective in essentially preventing the
induction of GADD153 protein expression caused by buty-
rate, as indicated by the absence of bright green fluorescence
(right upper image).
To help confirm the microscopic findings above, other
slides were prepared, doubly stained, and then examined
(Fig. 5A, lower set of images) using a triple-band filter to
permit simultaneous observation of red fluorescence (i.e.,
cells counterstained with propidium iodide to reveal their
presence and to verify that a similar number of cells was
FIG. 4. Effect of PD98059 on butyrate-induced upregula-
tion of GADD153 mRNA expression in HCT-116 colonocytes.
HCT-116 colonocytes were treated with 0–8 mM butyrate for
8 h, with trichostatin serving as a comparative positive con-
trol, in the absence and presence of 25mM PD98059 (A) or
50 mM PD98059 (B). Then, multiplex relative RT-PCR analy-
sis was performed to determine expression of the target
gene, GADD153, and internal control gene, b-actin. The bar
graphs above each of the representative gel images denote
the changes (fold differences, average SD) in GADD153
expression (normalized against b-actin) relative to control.
The results are representative of three different experiments.
FIG. 5. Effects of PD98059, SB203580, SP600125, and
staurosporine (SRS) on butyrate-induced upregulation of
GADD153 protein or mRNA expression in HCT-116 colo-
nocytes. In panel (A), HCT-116 colonocytes were treated
with 4 mM butyrate for 14 h in the absence and presence of
25mM PD98059. Then, immunocytofluorescence microscopy
was performed to assess GADD153 protein expression, using
anti-GADD153 primary antibody along with a secondary
antibody conjugated to Alexa Fluor 488 (green fluorescence).
Counterstaining was achieved with propidium iodide (red
fluorescence). The cells were viewed with a fluoroscein filter
and also with a triple-band filter. In panel (B), HCT-116 co-
lonocytes were incubated with butyrate for 8 h, but with
staurosporine (SRS), SB203580, or SP600125 being added at
the 4-h mid-time point to lessen potential cytotoxicity. Then,
multiplex relative RT-PCR analysis was performed to deter-
mine expression of the target gene, GADD153, and internal
control gene, b-actin. The bar graph above the representative
gel image denotes the changes (fold differences, average
SD) in GADD153 expression (normalized against b-actin)
relative to control. The results are representative of three
different experiments.
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present in the fields of view) and any green fluorescence (i.e.,
immunoreactivity of the cells with anti-GADD153 anti-
body=anti-rabbit IgG conjugated to Alexa Fluor 488, indica-
tive of the presence of GADD153 protein). In agreement with
the results shown in the upper images of Figure 5A, buty-
rate induced GADD153 protein expression to some extent
(middle lower image). This effect of butyrate was prevented
by PD98059 (right lower image).
Because the ERK inhibitor, PD98059, produced positive
results, selective chemical inhibitors of other MAPK were
evaluated similarly to gain more insight on the potential im-
portance of MAPK in mediating the effect of butyrate on
GADD153 mRNA expression. At the concentrations tested,
neither SB203580 (p38 MAPK inhibitor) nor SP600125 ( JNK
inhibitor) blunted butyrate-induced upregulation of GADD153
mRNA upregulation (Fig. 5B), in contrast to the blunting effect
previously found with PD98059 (Fig. 4A, B). In fact, SB203580
and SP600125 were subsequently found to increase GADD153
mRNA expression, when each inhibitor was tested alone (data
not shown). To evaluate a potential involvement of PKC in
mediating the effect of butyrate on GADD153 mRNA expres-
sion, an experiment with staurosporine (general or broad-
spectrum PKC inhibitor) was simultaneously conducted.
Staurosporine (SRS) prevented the increase in GADD153
mRNA expression caused by butyrate (Fig. 5B). However, it
was also subsequently found that staurosporine by itself (1mM)
seemed to produce morphological signs of apoptosis in HCT-
116 colonocytes (data not shown), which is consistent with the
reported effects of staurosporine on HT-29 human colon ade-
nocarcinoma cells (Qiao et al., 1996).
Finally, to determine if MEK, which is immediately up-
stream of ERK in the MAPK molecular cascade, might be
important in mediating upregulation of GADD153 mRNA
expression by butyrate, similar experiments as above were
performed utilizing the MEK inhibitor, U0126. As shown in
Figure 6A, U0126 blunted butyrate-induced upregulation of
GADD153 mRNA expression, and by itself did not affect
GADD153 mRNA. Further, as can be seen by the immuno-
cytofluorescence microscopy images obtained with three dif-
ferent filters (Fig. 6B), the overall interpretation is that U0126
prevented the perceptible upregulation of GADD153 protein
expression caused by butyrate. The rhodamine filter–based
images show the cells counterstained with propidium iodide
to reveal similar cell densities among the three samples an-
alyzed. Using a fluoroscein filter to examine the exact same
field of view, any GADD153 protein being expressed by the
cells can be visualized, as is the case with those cells emitting
the bright green fluorescence. Examining different fields of
view for the three samples with a triple-band filter corrob-
orated the observations above.
Discussion
Butyrate is often investigated because of a particular in-
terest in its possible chemopreventive effects against colon
cancer. Eating foods rich in dietary fiber supposedly lowers
the risk of colon cancer (Bingham et al., 2003). One plausible
explanation is that colonic microbes degrade the dietary fiber
to produce a beneficial metabolite, specifically butyrate, which
then suppresses the growth or proliferation of progenitor
colon cancer cells that otherwise would replicate to eventu-
ally form a tumor. This notion is based partly on several
studies (Nakano et al., 1997; Archer et al., 1998; Litvak et al.,
1998; Ruemmele et al., 2003), where butyrate was found to
inhibit cultured colon cancer cells from proliferating.
In the present study, HCT-116 human colon adenocarci-
noma cells exposed to millimolar concentrations of butyrate
within the physiological range (Topping and Clifton, 2001)
were studied because of the obvious relevance to the topic of
dietary fiber–derived short-chain fatty acids and colon can-
cer (Bingham et al., 2003). Evidence of apoptosis was found
in HCT-116 colonocytes exposed to butyrate. More specifi-
cally, examination of the cells by light microscopy and also
the results of the annexin V binding and TUNEL assays re-
vealed signs of apoptosis. These current findings corroborate
and expand similar findings by other workers studying the
apoptotic effects of butyrate (Ruemmele et al., 2003). It is well
known that oxidative damage to DNA can lead to apopto-
sis. Hence, in causing apoptosis, butyrate could have cre-
ated a state of oxidative stress resulting in DNA damage,
since it has been reported that butyrate can induce the pro-
FIG. 6. Selective MEK inhibitor, U0126, blunts induction of
GADD153 mRNA and protein caused by butyrate in HCT-116
colonocytes. The cells were treated with butyrate for 15 h in the
absence and presence of U0126. Then, multiplex relative RT-
PCR analysis was performed to determine GADD153 mRNA
expression (A). The bar graph above the representative gel
image denotes the changes (fold differences, average SD) in
GADD153 expression (normalized against b-actin) relative to
control. Also, cells were treated with butyrate for 14 h in
the absence and presence of U0126. Then, immunocytofluo-
rescence microscopy was performed to analyze GADD153
protein expression (B), using anti-GADD153 primary antibody
along with a secondary antibody conjugated to Alexa Fluor
488 (green fluorescence). Counterstaining was achieved with
propidium iodide (red fluorescence). The cells were viewed
with three different filters as indicated above for comparison.
The results are representative of three different experiments.
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duction of reactive oxygen species ( Jeng et al., 2006). How-
ever, no DNA damage was detected in HCT-116 colonocytes
exposed to butyrate, which is consistent with a study by
other workers (Rosignoli et al., 2001) using HT29 colonocytes
exposed to butyrate. Nevertheless, butyrate increased the
expression of GADD153 mRNA, although GADD153 pro-
tein was only slightly increased. Therefore, the upregulation
of GADD153 gene expression caused by butyrate is appar-
ently not a molecular response of the cells to DNA damage,
which was absent in butyrate-treated cells. One well-known
function of GADD153 is that it acts as a dominant-negative
inhibitor of the C=EBP family of transcription factors (Ron
and Habener, 1992), thereby enabling GADD153 protein to
indirectly regulate C=EBP-responsive genes. Other studies
(Conn et al., 2002; Kim et al., 2002; Lengwehasatit and
Dickson, 2002; Xia et al., 2002) have suggested that GADD153
somehow mediates the critical early events leading to the
initiation of apoptosis. However, in view of the current
finding that GADD153 protein was only slightly increased
in HCT-116 cells exposed to butyrate, it cannot be con-
cluded that GADD153 plays a pivotal role in butyrate-
induced apoptosis.
The ability of actinomycin D to essentially prevent buty-
rate-induced upregulation of GADD153 mRNA expres-
sion supports the probability that the effect of butyrate on
GADD153 mRNA was due primarily to increased transcrip-
tion rather than greater mRNA stability. However, it is known
that GADD153 mRNA levels can be upregulated in distinct
ways depending on the experimental conditions. For exam-
ple, greater GADD153 mRNA expression in leucine-deprived
cells was due to both increased transcription and mRNA
stability (Bruhat et al., 1997), whereas glutamine deprivation
increased GADD153 mRNA expression principally by stabi-
lizing mRNA transcript (Abcouwer et al., 1999). In contrast,
iron-deficient cells had greater GADD153 mRNA expression,
which was concluded to be attributed mainly to increased
transcription (Pan et al., 2004).
Regarding possible involvement of upstream protein
kinases in mediating butyrate-induced GADD153 mRNA
upregulation, MAPKs were given prime consideration for
current investigation because of other studies that have
identified a role for MAPK in upregulating GADD153 gene
expression as caused by other agents. As a case in point,
anisomycin caused activation of p38 MAPK in Jurkat
T-lymphocytes while also increasing GADD153 mRNA ex-
pression (Rolli-Derkinderen and Gaestel, 2000). However,
the effect of anisomycin on GADD153 mRNA was prevented
when the cells were pretreated with a selective chemical in-
hibitor of p38 MAPK. Similarly, chemical inhibition of p38
MAPK suppressed GADD153 mRNA upregulation caused
by peroxynitrite in human neuroblastoma SH-SY5Y cells
(Oh-Hashi et al., 2001). In another study, but with human
melanoma cells (Sarkar et al., 2002), ectopic overexpression
of the interleukin-24 (IL-24) gene via an adenovirus carrying
the IL-24 gene resulted in GADD153 gene upregulation that
was also found to be dependent on p38 MAPK. Recently, it
was reported (Li and Holbrook, 2004) that exposing primary
rat hepatocytes to agents that induce stress to the endo-
plasmic reticulum results in elevated GADD153 expression,
which was concluded to prominently involve JNK.
Taken together, the above studies (Rolli-Derkinderen
and Gaestel, 2000; Oh-Hashi et al., 2001; Sarkar et al., 2002;
Li and Holbrook, 2004) would generate the thought that
MAPK could be involved in butyrate-induced upregulation
of GADD153 gene expression as well. Based on the current
results of the experiments utilizing selective chemical inhib-
itors of p38 MAPK and JNK, it seems that p38 MAPK and
JNK do not play a role. Previously, butyrate was reported to
cause activation of ERK in K562 human erythroleukemic
cells (Rivero and Adunyah, 1996). Thus, in evaluating the
effects of other selective chemical inhibitors of MAPK, it
was found that the ERK inhibitor, PD98059, but also the
MEK inhibitor, U0126, noticeably attenuated the increased
GADD153 mRNA and protein expression caused by butyrate.
Therefore, these two new findings suggest that butyrate-
induced upregulation of GADD153 mRNA expression in-
volved at least the MEK=ERK branch of the MAPK cascade,
which adds to the base of knowledge on the signal trans-
duction events enabling butyrate to influence the GADD153
gene. In light of the rather diverse involvement of p38 MAPK
(Rolli-Derkinderen and Gaestel, 2000; Oh-Hashi et al., 2001;
Sarkar et al., 2002), JNK (Li and Holbrook, 2004), and ERK as
currently reported herein in mediating GADD153 gene up-
regulation, it appears that the particular experimental con-
ditions will largely determine which of the MAPK will be
pivotal in mediating the induction of GADD153 gene
expression. In any event, conventional wisdom holds that
activated MAPK would eventually promote activation of
specific transcription factors leading to transcriptional acti-
vation of the GADD153 gene.
On the other hand, it is conceivable that other protein ki-
nases are important in mediating the upregulatory effects of
butyrate on GADD153 gene expression. In seeming support of
this possibility with respect to PKC, it was observed that the
general PKC inhibitor, staurosporine, was able to prevent
butyrate-induced GADD153 mRNA upregulation in HCT-116
colonocytes. However, this observation should be interpreted
with caution because the results were achieved with only
relatively high concentrations of staurosporine, which can
also induce cell cycle arrest and apoptosis (Qiao et al., 1996). As
such, the role of PKC in mediating butyrate-induced GADD
153 gene activation remains uncertain and will require further
investigation, especially in view of the numerous known iso-
forms of PKC. Nevertheless, the present study is significant
because it sheds light on some aspects of a signaling cascade
facilitating GADD153 upregulation as caused by butyrate.
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